1 |
Shah MD, Balada-Llasat JM, Coe K, Reed E, Sandlund J, Pancholi P. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results. J Clin Microbiol 2020;58:e01681-19. [PMID: 32051264 DOI: 10.1128/JCM.01681-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
2 |
Emberger J, Hitchcock MM, Markley JD. Diagnostic Stewardship Approaches to Clostridioides difficile Infection in the Era of Two-Step Testing: a Shifting Landscape. Curr Treat Options Infect Dis 2020;12:258-74. [DOI: 10.1007/s40506-020-00223-8] [Reference Citation Analysis]
|
3 |
Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, du Toit B, Fredericks ES, Lekalakala-Mokaba MR, Maluleka C, Rajabally MN, Reubenson G, Shuping L, Swart K, Swe Han KS, Wadula J, Wojno J, Lowman W. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. S Afr J Infect Dis 2020;35:219. [PMID: 34485483 DOI: 10.4102/sajid.v35i1.219] [Reference Citation Analysis]
|
4 |
Boly FJ, Reske KA, Kwon JH. The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities. Curr Infect Dis Rep 2020;22:7. [PMID: 33762897 DOI: 10.1007/s11908-020-0715-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
5 |
Widmer AF, Frei R, Kuijper EJ, Wilcox MH, Schindler R, Spaniol V, Goldenberger D, Egli A, Tschudin-Sutter S. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland. Emerg Infect Dis 2020;26:2370-7. [PMID: 32946368 DOI: 10.3201/eid2610.190804] [Reference Citation Analysis]
|
6 |
Hara T, Suzuki H, Oyanagi T, Koyanagi N, Ushiki A, Kawabata N, Goto M, Hida Y, Yaguchi Y, Tamai K, Notake S, Kawashima Y, Sugiyama A, Uemura K, Kashiyama S, Nanmoku T, Suzuki S, Yamazaki H, Kimura H, Kunishima H, Ohge H. Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens. PLoS One 2020;15:e0234119. [PMID: 32492051 DOI: 10.1371/journal.pone.0234119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|